The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday preview: US tech titans, AstraZeneca in focus

Wed, 29th Jul 2020 16:19

(Sharecast News) - The market spotlight will fall on earnings reports from several of the largest corporates in the States, as they update shareholders on their performance over the three months to June, including Amazon, Alphabet, Facebook, and Microsoft.




But the US economy won't be far from investors minds either, as the Commerce Department releases second quarter US gross domestic product data that economists at Barclays Research anticipate will show an annualised 35% drop in activity.

Some analysts believe that their updates may well set the tone for over the entire month of August.

In the UK on the other hand, the only noteworthy release will be for motor vehicle production in June.

Across the Channel meanwhile, readings are due out for monthly unemployment in Germany and Italy, alongside second quarter GDP readings in Austria, Belgium and Germany.



The earnings calendar for the UK is full on Thursday

In the case of AstraZeneca, UBS analyst Michael Leuchten sees first half revenues coming in at $6.33bn (consensus: $6.25bn) and core earnings per share at $0.93 (consensus: $0.92).

Focus would be on the drugmaker's work on a Covid-19 vaccine alongside Oxford University, which was currently considered the front-runner in the global race to find a vaccine.

But concerns around cash generation were likely to resurface as well.

"Top-line momentum remains key for investors, in particular Tagrisso (UBSe of $1,013m vs cons. $1,031m), Lynparza (UBSe of $460m vs cons. $412m) and Imfinzi (UBSe $478m vs cons $465m). Calquence uptake will be of interest (UBSe of $102m vs cons. $103m). We will also look for any commentary around COVID-19 potential impact in H2 and the path to recovery."

Thursday 29 July

FINALS

The Panoply Holdings

INTERIMS

SEGRO, Kcell Joint Stock Co GDR (Reg S), BAE Systems, Franchise Brands, Greencoat UK Wind, Hutchison China Meditech Ltd, Inchcape, Robert Walters, Rentokil Initial, Goco Group, Schroders, AstraZeneca

Q2

Schroders, AstraZeneca, Royal Dutch Shell 'A', Royal Dutch Shell 'B'

TRADING ANNOUNCEMENTS

Compass Group, Gem Diamonds Ltd. (DI), Evraz, Volution Group

AGMs

Norcros, Card Factory, OnTheMarket, BMO Global Smaller Companies, Highland Gold Mining Ltd., Volex, London & Associated Properties, TMT Investments, Angling Direct, Gabelli Value Plus Trust, Stobart Group Ltd.

FINAL EX-DIVIDEND DATE

Anexo Group, Ventus 2 VCT 'C' Shares, Monks Inv Trust, Ventus VCT, Ventus 2 VCT D Shs, Keller Group, Ventus 2 VCT, Ventus VCT D Shs

FINAL DIVIDEND PAYMENT DATE

Anglo Asian Mining

INTERIM EX-DIVIDEND DATE

Investment Company, Hansa Investment Company Limited (DI), Aberdeen Asian Income Fund Ltd., BB Healthcare Trust (Red), Hansa Investment Company Limited 'A' Non Vtg (DI), Independent Inv Trust, Secure Income Reit, RELX plc, Nichols, Blackstone/GSO Loan Financing Limited, Blackrock Throgmorton Trust, GCP Infrastructure Investments Ltd, Aew UK Reit, Value and Income Trust, Henderson International Income Trust, Maven Income and Growth VCT 5, Schroder Real Estate Investment Trust Ltd, Starwood European Real Estate Finance Ltd, GCP Asset Backed Income Fund Limited, Henderson Far East Income Ltd., Maven Income & Growth 3 VCT, Foresight Solar Fund Limited, Ecofin Global Utilities and Infrastructure Trust

INTERIM DIVIDEND PAYMENT DATE

Robinson

SPECIAL EX-DIVIDEND DATE

Keller Group

QUARTERLY EX-DIVIDEND DATE

Marble Point Loan Financing Limited NPV, SME Credit Realisation Fund Limited NPV, City of London Inv Trust

QUARTERLY PAYMENT DATE

Real Estate Credit Investments Ltd

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Unemployment Rate (GER) (08:55)

GDP (Preliminary) (GER) (09:00)

Business Climate Indicator (EU) (10:00)

Industrial Confidence (EU) (10:00)

Economic Sentiment Indicator (EU) (10:00)

Unemployment Rate (EU) (10:00)

Services Sentiment (EU) (10:00)

Services Confidence (EU) (10:00)

GDP (Preliminary) (US) (13:30)

Continuing Claims (US) (13:30)

Initial Jobless Claims (US) (13:30)



More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.